Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06272968

Predicting Cognition After DBS for Parkinson's Disease 2

Sponsor: Charite University, Berlin, Germany

View on ClinicalTrials.gov

Summary

The aim of the study is to improve estimation of cognitive outcome after STN-DBS in PD in order to avoid risk factors by optimizing peri- and intraoperative management personalize therapeutic strategies for optimal long-term benefit. The investigators will test possible predictors (clinical, neuropsychological, neuroimaging, electrophysiological and molecular) for the risk of cognitive dysfunction after deep brain stimulation of the subthalamic nucleus (STN-DBS) in Parkinson's disease (PD) at a single center (Charité - Universitätsmedizin Berlin, Germany). Data collection takes place prior to as well as 3, 12 and 60 months after the STN-DBS operation. Participation is proposed to all PD patients that are planned to undergo STN-DBS after careful examination of eligibility for this treatment according to standard operation procedures.

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

OBSERVATIONAL

Enrollment

30

Start Date

2024-10-01

Completion Date

2030-12-01

Last Updated

2025-09-09

Healthy Volunteers

No

Interventions

DIAGNOSTIC_TEST

Neuropsychological Testing

Neuropsychological Testing via Cambridge CANTAB Connect

Locations (1)

Charité - Universitätsmedizin Berlin

Berlin, Germany